Dashboard
Manage Tickers

DAWN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

day-one-biopharmaceuticals-files-for-offering-of-up-to-121m-shares-by-the-selling-stockholders
Day One Biopharmaceuticals Files For Offer...
08/28/2024 20:14:55

-SEC

jp-morgan-maintains-overweight-on-day-one-biopharmaceutical-lowers-price-target-to-36
JP Morgan Maintains Overweight on Day One ...
08/06/2024 16:16:55

JP Morgan analyst Anupam Rama maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and lowers the price targe...

meta-to-rally-around-35-here-are-10-top-analyst-forecasts-for-thursday
Meta To Rally Around 35%? Here Are 10 Top ...
08/01/2024 12:17:30

day-one-biopharmaceuticals-shares-are-trading-higher-after-b-of-a-securities-upgraded-the-stock-from-underperform-to-buy-and-raised-its-price-target-from-11-to-24
Day One Biopharmaceuticals shares are trad...
08/01/2024 11:39:59

hc-wainwright--co-reiterates-buy-on-day-one-biopharmaceutical-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Day ...
08/01/2024 10:32:55

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

b-of-a-securities-upgrades-day-one-biopharmaceutical-to-buy-raises-price-target-to-24
B of A Securities Upgrades Day One Biophar...
08/01/2024 10:09:51

B of A Securities analyst Alec Stranahan upgrades Day One Biopharmaceutical (NASDAQ:DAWN) from Underperform to Buy and raise...

needham-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-32
Needham Maintains Buy on Day One Biopharma...
07/31/2024 09:30:42

Needham analyst Ami Fadia maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the price target from $33 ...

needham-reiterates-buy-on-day-one-biopharmaceutical-maintains-33-price-target
Needham Reiterates Buy on Day One Biopharm...
07/30/2024 15:38:06

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $33 price target.

day-one-biopharmaceutical-q2-2024-gaap-eps-005-may-not-be-comparable-to-066-estimate-sales-8192m-may-not-be-comparable-to-1022m-estimate
Day One Biopharmaceutical Q2 2024 GAAP EPS...
07/30/2024 11:39:39

day-one-biopharmaceuticals-announced-an-oversubscribed-private-placement-of-gross-proceeds-of-approximately-175m-offering-1055m-shares-at-1450-per-share
Day One Biopharmaceuticals Announced An Ov...
07/30/2024 11:17:43

The private placement will be for 10,551,718 shares of common stock at a price of $14.50 per share. In lieu of shares of common...

hc-wainwright--co-reiterates-buy-on-day-one-biopharmaceutical-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Day ...
07/26/2024 11:52:23

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

why-indivior-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Indivior Shares Are Trading Higher; He...
07/25/2024 10:36:30

Core News & Articles
Ipsen And Day One Earlier Announced Exclus...
07/25/2024 10:10:04

Ipsen ((Euronext: IPN, OTC:IPSEY) and Day One Biopharmaceuticals (NASDAQ:DAWN) (Day One), announced today a new global partners...

Core News & Articles
Ipsen And Day One Enter Ex-U.S. Licensing ...
07/25/2024 05:54:41

Ipsen secures ex-U.S. regulatory and commercial rights to tovorafenib for most common childhood brain tumor, pediatric low-gr...

piper-sandler-maintains-overweight-on-day-one-biopharmaceutical-maintains-40-price-target
Piper Sandler Maintains Overweight on Day ...
07/08/2024 13:09:00

Piper Sandler analyst Joseph Catanzaro maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Overweight and maintains $40...

hc-wainwright--co-reiterates-buy-on-day-one-biopharmaceutical-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Day ...
06/20/2024 10:13:00

HC Wainwright & Co. analyst Andres Maldonado reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains...

needham-reiterates-buy-on-day-one-biopharmaceutical-maintains-33-price-target
Needham Reiterates Buy on Day One Biopharm...
06/19/2024 09:37:14

Needham analyst Ami Fadia reiterates Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and maintains $33 price target.

day-one-biopharmaceuticals-enters-exclusive-licensing-agreement-with-mabcare-therapeutics-for-mtx-13-ind-cleared-by-fda-in-april-2024-targets-ptk7-in-adult-and-pediatric-solid-tumors
Day One Biopharmaceuticals Enters Exclusiv...
06/18/2024 12:34:04

day-one-to-sell-priority-review-voucher-for-108m
Day One To Sell Priority Review Voucher Fo...
05/30/2024 12:32:47

As part of the transaction, $8.1 million of the total consideration received from the sale of the PRV will be paid to Viracta T...

hc-wainwright--co-maintains-buy-on-day-one-biopharmaceutical-lowers-price-target-to-40
HC Wainwright & Co. Maintains Buy on Day O...
05/07/2024 10:53:34

HC Wainwright & Co. analyst Andres Maldonado maintains Day One Biopharmaceutical (NASDAQ:DAWN) with a Buy and lowers the...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION